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SCN8A is one of an increasing number of genes encoding neuronal
sodium channels associated with early-onset epileptic encephalop-
athies. The SCN8A-encoded sodium channel alpha subunit Nav1.6 is
concentrated at the axon initial segment in both excitatory and
inhibitory neurons and nodes of Ranvier in motor neurons, resulting,
if mutated, in dysregulation of neuronal excitability and motor
dysfunction [1]. SCN8A mutations have been mainly associated with
early-onset epileptic encephalopathies, developmental delay and
movement disorders. The associated phenotype continues to
expand [2–4]. We report a unique phenotype with in utero onset
of movement disorder, with evolving epilepsy, epileptic encepha-
lopathy and developmental delay.
2. Case report
Our proband was the ﬁrst child of healthy nonconsanguineous,
Caucasian parents born at 40 + 3 weeks gestation by ventouse
delivery. He did not require any resuscitation. Growth parameters
including head circumference were on the 9th percentile and there
was no dysmorphism. His mother had noticed unusual ‘‘drumming’’
in utero movements in the later stages of pregnancy, with normal
antenatal scans. Shortly after birth he was noted to have jittery
movements and a pathologically exaggerated startle response to
tactile and acoustic stimuli, prompting a suspicion of hyperek-
plexia. At 15 h of age he had an asymmetrical clonic seizure,* Corresponding author at: Children’s Neurosciences Centre, F01 – Staircase D
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admission to the neonatal intensive care unit. His initial
amplitude integrated EEG and cerebral function monitor were
normal. His EEG on day 4 showed a normal background, 5–8 Hz
irregular jittery movements of all four limbs picked up on EMG
polygraphy electrodes. These movements were stimulus sensitive
and their severity increased when he was distressed. He had
occasional sharp transients over the vertex, with no ictal EEG
correlate to the jittery movements (Video 1 and Fig. 1). Subse-
quent overnight video telemetry demonstrated a build up of low
voltage fast activity at the centro-parietal regions bilaterally at
the onset with augmentation of the jittery movements as seen on
EMG polygraph. This is followed by centroparietal evolution of
spikes bilaterally during the tonic phase of seizure (witnessed in
video as elevation of both his legs) followed by generalisation of
spike and wave discharges during the apnoeic phase with post
ictal accentuation at the offset (Video 2 and Fig. 2).
He went on to develop frequent stereotyped tonic/tonic-clonic
seizures progressing to epileptic status. Seizures continued despite
treatment. The seizure pattern changed from around 3 months,
featuring predominantly tonic seizures later on accompanied by
apnoeas requiring multiple paediatric intensive care unit (PICU)
admissions. Therapeutic trials with several anticonvulsants including
clonazepam, vigabatrin, topiramate, levetiracetam, carabamaze-
pine, sodium valproate, phenobarbital, lacosamide were unsuc-
cessful in terms of seizure control, as was the ketogenic diet.
High therapeutic levels of phenytoin (18–20 mg/L) appeared to
provide some initial beneﬁt but this was not sustained. He
continued to have an exaggerated startle, paroxysmal posturing
and jittery movements subsiding in sleep that on clinical and
encephalographic grounds were not epileptic in nature. During
such episodes he became extremely distressed and appeared toserved.
Fig. 1. EEG at the time of Jittery episode (Video 1).
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paediatric emergency services and leading to the consideration
of an acute abdomen in the differential diagnosis. He was tried
on propranolol, piracetam, gabapentin and clonidine for his
persistent and non-ictal jittery movements, with no sustainable
effect. He had progressive difﬁculty feeding requiring gastro-
stomy insertion. He developed peripheral hypertonia with a
generalised paucity and lack of purposeful movements and
central hypotonia. He was only intermittently visually respon-
sive and able to smile. His head circumference dropped from the
9th to below 0.4th percentile (43 cm).
MRI of the brain at 7 days of age was normal. Repeat
neuroimaging including MR spectroscopy at 4 months showed
mild cerebellar volume loss with age-appropriate myelination.
Extensive metabolic investigations were negative. Mutation
screening through a next generation sequencing panel covering
48 genes associated with severe developmental delay and early-
onset epileptic encephalopathies epilepsy identiﬁed a de novo
dominant SCN8A (c.3979A>G; p.Ile1327Val) mutation.
3. Discussion
Over the past year there have been a number of cases of
pathogenic SCN8A mutations described including a recent case
series of 17 patients [2–4]. The majority of mutations are of
de novo inheritance and all the reported pathogenic mutations are
distributed throughout the SCN8A gene. The clinical phenotype is
characterised by early onset intractable seizures progressing to
epileptic encephalopathy and severe disability. Various motormanifestations have been described including hypotonia, spastici-
ty, dystonia, ataxia and choreoathetosis [2] but in only 1 other
patient [3], sharing the same genetic mutation as our case, has a
severe early onset movement disorder been described. There does
not appear to be any phenotype genotype correlation in the cases
reported although our case and the one described by Vaher et al. [3]
are strikingly similar. Our patient had a de novo dominant SCN8A
mutation, possibly associated with a gain-of-function of the
NaV1.6 channel with probable in utero onset of movement
disorder. The SCN8A-associated seizure phenotype mainly com-
prises focal clonic seizures evolving to bilateral convulsive
seizures, tonic seizures, tonic clonic seizures, and epileptic spasms.
Additionally both convulsive and non convulsive status appear to
be common [2]. There do not appear to be any pathognomic
interictal EEG abnormalities and in the majority of previously
reported cases initial EEG’s (where available) were normal or
showed only mild changes. Progressive MRI changes are described
in a number of patients with cerebral atrophy and in some cases as
in our patient, cerebellar atrophy.
Our case illustrates that SCN8A mutations may give rise to
pathologically exaggerated startle; increased jitteriness and an
early-onset movement disorder even before clinical or electro-
encephalographic evidence for the more typical epileptic
encephalopathy, and have to be considered in the differential
diagnosis of non-epileptic hyperexcitability syndromes such as
hyperekplexia. Epileptic and non-epileptic manifestations of
defective NaV1.6 function in the same child may be difﬁcult to
distinguish and pose substantial diagnostic and management
challenges. More widely available epilepsy genetic diagnostic
Fig. 2. EEG changes, during video telemetry showing episode of tonic seizures involving both lower limbs, followed by ictal changes (Video 2).
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spectrum further and to delineate the associated movement
disorder in more detail.
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